Tirzepatide was superior to semaglutide in achieving standard and intensive cardiometabolic targets among patients with type ...

Study comparing bariatric surgery to GLP-1 medications shows 24% total weight loss from surgery versus 4.7% from injectables, ...

A large network meta-analysis ranked eight GLP-1 receptor agonists for glycemic, weight, and safety outcomes in adults with type 2 diabetes. Tirzepatide demonstrated the greatest efficacy for glucose ...

Ozempic is an FDA-approved medication for people who have type 2 diabetes. It’s often prescribed “off-label” for weight loss ...

Hormone therapy as an adjunctive to tirzepatide was associated with greater weight loss than tirzepatide alone among postmenopausal women.

There’s no such thing as "natural Ozempic." While supplements like psyllium, berberine, and glucomannan are paraded as ...

A new study suggests that eating more protein while taking GLP-1 medications could help prevent muscle loss, a common side ...

A higher proportion of sleep medicine providers vs. patients reported CPAP over tirzepatide as their preferred treatment option for comorbid obesity and obstructive sleep apnea, according to data ...

Weight-loss injections have been found less effective in real-life scenarios than in controlled lab settings, with usage patterns playing a significant role, according to new research. Semaglutide ...

Obesity costs U.S. health care nearly $173 billion yearly. With more than 200 related complications such as heart disease, ...

Bariatric surgery shows better real-life results than GLP-1s in a study: the scalpel achieves five times more weight loss than pharmacological treatment at two years.At two years, bariatric surgery ...

Adults with obesity were more likely to achieve a 10% or greater weight loss at 1 year if they continued using their ...